These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 21787818

  • 1. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
    Xiao K, Luo J, Li Y, Lee JS, Fung G, Lam KS.
    J Control Release; 2011 Oct 30; 155(2):272-81. PubMed ID: 21787818
    [Abstract] [Full Text] [Related]

  • 2. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
    Lu J, Zhao W, Huang Y, Liu H, Marquez R, Gibbs RB, Li J, Venkataramanan R, Xu L, Li S, Li S.
    Mol Pharm; 2014 Nov 03; 11(11):4164-78. PubMed ID: 25265550
    [Abstract] [Full Text] [Related]

  • 3. Stability influences the biodistribution, toxicity, and anti-tumor activity of doxorubicin encapsulated in PEG-PE micelles in mice.
    Wei X, Wang Y, Zeng W, Huang F, Qin L, Zhang C, Liang W.
    Pharm Res; 2012 Jul 03; 29(7):1977-89. PubMed ID: 22426964
    [Abstract] [Full Text] [Related]

  • 4. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y, Lu Y, Wang L, Lu W, Huang J, Muir B, Yu J.
    Colloids Surf B Biointerfaces; 2016 May 01; 141():318-326. PubMed ID: 26874117
    [Abstract] [Full Text] [Related]

  • 5. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
    Min KH, Lee HJ, Kim K, Kwon IC, Jeong SY, Lee SC.
    Biomaterials; 2012 Aug 01; 33(23):5788-97. PubMed ID: 22591612
    [Abstract] [Full Text] [Related]

  • 6. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
    Zhu Y, Zhang J, Meng F, Deng C, Cheng R, Feijen J, Zhong Z.
    J Control Release; 2016 Jul 10; 233():29-38. PubMed ID: 27178807
    [Abstract] [Full Text] [Related]

  • 7. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F.
    Eur J Pharm Biopharm; 2015 Aug 10; 94():521-31. PubMed ID: 26170161
    [Abstract] [Full Text] [Related]

  • 8. Targeted delivery of doxorubicin-loaded poly (ε-caprolactone)-b-poly (N-vinylpyrrolidone) micelles enhances antitumor effect in lymphoma.
    Hira SK, Mishra AK, Ray B, Manna PP.
    PLoS One; 2014 Aug 10; 9(4):e94309. PubMed ID: 24714166
    [Abstract] [Full Text] [Related]

  • 9. Riboflavin-containing telodendrimer nanocarriers for efficient doxorubicin delivery: High loading capacity, increased stability, and improved anticancer efficacy.
    Guo D, Shi C, Wang X, Wang L, Zhang S, Luo J.
    Biomaterials; 2017 Oct 10; 141():161-175. PubMed ID: 28688287
    [Abstract] [Full Text] [Related]

  • 10. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor.
    Kim D, Lee ES, Park K, Kwon IC, Bae YH.
    Pharm Res; 2008 Sep 10; 25(9):2074-82. PubMed ID: 18449626
    [Abstract] [Full Text] [Related]

  • 11. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.
    Ye WL, Zhao YP, Li HQ, Na R, Li F, Mei QB, Zhao MG, Zhou SY.
    Sci Rep; 2015 Sep 30; 5():14614. PubMed ID: 26419507
    [Abstract] [Full Text] [Related]

  • 12. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice.
    Gao ZG, Lee DH, Kim DI, Bae YH.
    J Drug Target; 2005 Aug 30; 13(7):391-7. PubMed ID: 16308207
    [Abstract] [Full Text] [Related]

  • 13. Bile Acid-Based Drug Delivery Systems for Enhanced Doxorubicin Encapsulation: Comparing Hydrophobic and Ionic Interactions in Drug Loading and Release.
    Cunningham AJ, Robinson M, Banquy X, Leblond J, Zhu XX.
    Mol Pharm; 2018 Mar 05; 15(3):1266-1276. PubMed ID: 29378128
    [Abstract] [Full Text] [Related]

  • 14. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy.
    Zou Y, Fang Y, Meng H, Meng F, Deng C, Zhang J, Zhong Z.
    J Control Release; 2016 Dec 28; 244(Pt B):326-335. PubMed ID: 27245309
    [Abstract] [Full Text] [Related]

  • 15. The effect of kinetic stability on biodistribution and anti-tumor efficacy of drug-loaded biodegradable polymeric micelles.
    Attia AB, Yang C, Tan JP, Gao S, Williams DF, Hedrick JL, Yang YY.
    Biomaterials; 2013 Apr 28; 34(12):3132-40. PubMed ID: 23380357
    [Abstract] [Full Text] [Related]

  • 16. Reversibly disulfide cross-linked micelles improve the pharmacokinetics and facilitate the targeted, on-demand delivery of doxorubicin in the treatment of B-cell lymphoma.
    Xiao K, Liu Q, Al Awwad N, Zhang H, Lai L, Luo Y, Lee JS, Li Y, Lam KS.
    Nanoscale; 2018 May 03; 10(17):8207-8216. PubMed ID: 29682647
    [Abstract] [Full Text] [Related]

  • 17. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
    Talelli M, Iman M, Varkouhi AK, Rijcken CJ, Schiffelers RM, Etrych T, Ulbrich K, van Nostrum CF, Lammers T, Storm G, Hennink WE.
    Biomaterials; 2010 Oct 03; 31(30):7797-804. PubMed ID: 20673684
    [Abstract] [Full Text] [Related]

  • 18. PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.
    Xu M, Zhang CY, Wu J, Zhou H, Bai R, Shen Z, Deng F, Liu Y, Liu J.
    ACS Appl Mater Interfaces; 2019 Feb 13; 11(6):5701-5713. PubMed ID: 30644711
    [Abstract] [Full Text] [Related]

  • 19. Folate receptor targeted biodegradable polymeric doxorubicin micelles.
    Yoo HS, Park TG.
    J Control Release; 2004 Apr 28; 96(2):273-83. PubMed ID: 15081218
    [Abstract] [Full Text] [Related]

  • 20. Targeted delivery by pH-responsive mPEG-S-PBLG micelles significantly enhances the anti-tumor efficacy of doxorubicin with reduced cardiotoxicity.
    Feng Q, Xu J, Liu X, Wang H, Xiong J, Xiao K.
    Drug Deliv; 2021 Dec 28; 28(1):2495-2509. PubMed ID: 34842005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.